Xellia Pharms Aps Company Profile
What is the competitive landscape for XELLIA PHARMS APS
XELLIA PHARMS APS has ten approved drugs.
Drugs and US Patents for Xellia Pharms Aps
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xellia Pharms Aps | DAPTOMYCIN | daptomycin | POWDER;INTRAVENOUS | 206005-001 | Jun 15, 2016 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Xellia Pharms Aps | COLISTIMETHATE SODIUM | colistimethate sodium | INJECTABLE;INJECTION | 205356-001 | May 29, 2015 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Xellia Pharms Aps | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | INJECTABLE;INJECTION | 206243-002 | Dec 23, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Xellia Pharms Aps | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | INJECTABLE;INJECTION | 091377-001 | Sep 9, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Xellia Pharms Aps | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | INJECTABLE;INJECTION | 204125-002 | Dec 28, 2015 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

